Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Dave Denton will step down as CFO in August; Cecile Guegan will serve as Interim CFO.
By: Charlie Sternberg
RayThera’s portfolio includes multiple anti-inflammatory assets that could potentially treat immune-mediated conditions across a range of indications.
A U.S. jury has found Amgen liable for patent infringement against Harbour BioMed.
Nathan Meehan, Process Engineer, Lifecore Injectables CDMO, offers expert insights on terminal sterilization, sterile filtration, aseptic processing and Annex 1 compliance.
Released By Lifecore Injectables CDMO
Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation requires tighter coordination across formulation, characterization, and preclinical testing.
By: Tim Wright
Pfizer Announces Search for New Chief Financial Officer
GSK Agrees to Acquire Nuvalent for $10.6B
Risk Isn’t Inevitable: How the Right CDMO Partnership Protects Your Program
An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer
As pharma companies rethink global supply networks, CPHI Americas puts regional resilience, contract manufacturing, and long-term outsourcing partnerships at the center of the conversation.
By: Sara Griffin
Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.
By: Dan Stanton
We got an up-close look at the Superbox during INTERPHEX 2026 in New York City.
By: Patrick Lavery
Subscribe to Magazine for top news, trends & analysis
Evotec team shares insight on addressing solubility and bioavailability challenges for today’s complex molecules.
Released By EVOTEC
Brian McCollum walks us through Glatt’s capabilities and technologies available at its Ramsey, NJ site from development to commercialization.
Released By Glatt Air Techniques
Jai Murthy of Actylis shares insight on overcoming supply chain fragility, buffer prep solutions, and approaches to customization.
Released By Actylis
Pfizer
Merck
Johnson & Johnson
Abbvie
AstraZeneca
Roche
Novartis
Bristol Myers Squibb
Lilly
Sanofi
In this Q&A, Ingenza CEO Nick Challoner, discusses how CRDMOs must evolve to help biotech companies accelerate development, reduce risk, and translate scientific innovation into scalable commercial success.
Alliances and expertise behind advancing CGTs in today’s market.
By: Kristin Brooks
As development programs become more complex, sponsors increasingly benefit from a coordinated approach that connects clinical strategy, CMC, manufacturing, and supply planning.
Released By Thermo Fisher Scientific Pharma Services
Dr. Max Lauwiner, CEO of Valsynthese, discusses the role of small-sized CDMOs in securing Pharma innovation pipelines.
Released By Valsynthese
Plasmid DNA is a critical starting material for cell and gene therapies, viral vectors, mRNA therapeutics, and DNA vaccines, but manufacturing it consistently at the required quality and scale can present significant technical and operational challenges.
This webinar will examine key considerations for optimizing plasmid design, process development, production, and analytical control across development stages. Attendees will learn how advanced plasmid engineering, high-performance production strains, scalable purification technologies, and phase-appropriate quality strategies can help improve yield, supercoiling, ITR integrity, and manufacturing timelines.
The session will also explore how an integrated approach spanning plasmid design, CMC development, analytics, and GMP manufacturing can reduce risk and support programs from preclinical development through commercialization.
Sponsored By ProBio CDMO
3D printing is rapidly changing the future of pharmaceutical manufacturing by creating new opportunities in formulation design, drug delivery, and patient focused therapies. Adare’s Giuseppe De Franza, Director, Research and Development Italy, will discuss how 3D screen printing is helping reshape traditional pharmaceutical processes and enabling innovative solutions for complex therapeutic challenges. This webinar will explore the advantages of 3D printing compared to conventional manufacturing methods, including the ability to develop complex drug release profiles and smart drug delivery systems tailored to patient needs. Real world examples featuring Carbidopa/Levodopa applications and gummy delivery systems will highlight how advanced manufacturing technologies are driving flexibility, innovation, and improved patient outcomes.
Sponsored By Adare Pharma Solutions
Learn how to optimize your supplier qualification process while significantly lowering both risk and the total cost of quality. This session examines the true cost of conducting supplier audits and presents practical, proven strategies to reduce it without compromising compliance or patient safety. You will discover the most commonly overlooked audit findings that create hidden compliance and safety risks, along with effective ways to identify and prevent them. The session also evaluates the substantial risks and inefficiencies of traditional manual supplier qualification programs and explores smarter, more efficient alternatives.
Sponsored By SGS North America, Inc.
A closer look at the communication, scale-up, equipment, and collaboration challenges that can make or break a successful tech transfer.
A closer look at how CDMOs safely handle volatile chemistry to transform isoprene into high-value specialty products.
R&D Chemist and Project Manager Luca Allievi on nitration, phosgenation, and the power of DoE in sustainable process development.
Phase II starts are increasing the fastest of all clinical phases, trials are running leaner, and the safety data challenge is growing.
By: Patrick Hughes
As sponsor needs change strategic collaboration with CDMOs/CROs is becoming more important for execution and early input.
By: Luke Wilson, Amanda Bosse
Key trends and opportunities in today’s evolving CRO landscape.
By: Stephen Corson
The company hopes to bridge spatial biomarker discovery and clinical translation.
Degron’s lead program, DEG6498, entered the clinic in late 2025.
The new capital supports expansion of Moleculent’s Techstart Early Access Program.
Dr. Rodolfo Romañach and Dr. Rafael Méndez from the University of Puerto Rico, Mayagüez, present a stream sampler for real-time monitoring of powder blends.
The particle size of the API and excipients affects more than just the stability and appearance of the product.
It’s not your Mom’s way, anymore.
By: Emil W. Ciurczak
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
